Peptide-Based Matrices as Drug Delivery Vehicles

被引:24
作者
Ezzat, Kariem [1 ]
El Andaloussi, Samir [1 ]
Abdo, Rania [1 ]
Langel, Ulo [1 ]
机构
[1] Stockholm Univ, Dept Neurochem, Arrhenius Labs Nat Sci, SE-10691 Stockholm, Sweden
关键词
Cell penetrating peptide; protein transduction domain; delivery; siRNA; splice correction; Poly-L-lysine; antimicrobial peptides; CELL-PENETRATING PEPTIDES; ARGININE-RICH PEPTIDES; ANTISENSE MORPHOLINO OLIGOMERS; ANTENNAPEDIA HOMEOBOX PEPTIDE; EFFICIENT SPLICING CORRECTION; HUMAN IMMUNODEFICIENCY VIRUS; VECTOR-MEDIATED STRATEGY; SINGLE-CHAIN ANTIBODIES; PLURIPOTENT STEM-CELLS; ISCHEMIC BRAIN-INJURY;
D O I
10.2174/138161210790963832
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Peptides, polypeptides, and proteins have been extensively studied for their various structural and functional roles in living organisms. However, breakthrough discoveries in the last decades identified some peptide-based matrices that posses the ability to traverse biological membranes, and many peptides, polypeptides and even complete proteins have been shown to have such properties. Hence, these matrices have been successfully used for the intracellular delivery of many therapeutic cargos including small molecules, proteins, peptides, oligonucleutides, plasmids and nanoparticles both in vitro and in vivo. Being neither toxic nor carcinogenic and meanwhile efficient in delivery, they are recognized as very promising vectors to overcome the shortcomings of the available technologies. The characteristics of these peptide-based matrices and their applications in drug delivery are here briefly illustrated together with current challenges and future prospects.
引用
收藏
页码:1167 / 1178
页数:12
相关论文
共 141 条
[31]   VE-cadherin-derived cell-penetrating peptide, pVEC, with carrier functions [J].
Elmquist, A ;
Lindgren, M ;
Bartfai, T ;
Langel, U .
EXPERIMENTAL CELL RESEARCH, 2001, 269 (02) :237-244
[32]   Tumour-homing peptides:: tools for targeting, imaging and destruction [J].
Enback, J. ;
Laakkonen, P. .
BIOCHEMICAL SOCIETY TRANSACTIONS, 2007, 35 :780-783
[33]   NLS bioconjugates for targeting therapeutic genes to the nucleus [J].
Escriou, V ;
Carrière, M ;
Scherman, D ;
Wils, P .
ADVANCED DRUG DELIVERY REVIEWS, 2003, 55 (02) :295-306
[34]   Pre-mRNA splicing and human disease [J].
Faustino, NA ;
Cooper, TA .
GENES & DEVELOPMENT, 2003, 17 (04) :419-437
[35]   TAT-MEDIATED DELIVERY OF HETEROLOGOUS PROTEINS INTO CELLS [J].
FAWELL, S ;
SEERY, J ;
DAIKH, Y ;
MOORE, C ;
CHEN, LL ;
PEPINSKY, B ;
BARSOUM, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (02) :664-668
[36]   Cellular delivery of a double-stranded oligonucleotide NFκB decoy by hybridization to complementary PNA linked to a cell-penetrating peptide [J].
Fisher, L ;
Soomets, U ;
Toro, VC ;
Chilton, L ;
Jiang, Y ;
Langel, Ü ;
Iverfeldt, K .
GENE THERAPY, 2004, 11 (16) :1264-1272
[37]   Morpholino oligomer -: Mediated Exon skipping averts the onset of dystrophic pathology in the mdx mouse [J].
Fletcher, Sue ;
Honeyman, Kaite ;
Fall, Abbie M. ;
Harding, Penny L. ;
Johnsen, Russell D. ;
Steinhaus, Joshua P. ;
Moulton, Hong M. ;
Iversen, Patrick L. ;
Wilton, Stephen D. .
MOLECULAR THERAPY, 2007, 15 (09) :1587-1592
[38]   CELLULAR UPTAKE OF THE TAT PROTEIN FROM HUMAN IMMUNODEFICIENCY VIRUS [J].
FRANKEL, AD ;
PABO, CO .
CELL, 1988, 55 (06) :1189-1193
[39]   Pathway for polyarginine entry into mammalian cell [J].
Fuchs, SM ;
Raines, RT .
BIOCHEMISTRY, 2004, 43 (09) :2438-2444
[40]   Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo [J].
Fulda, S ;
Wick, W ;
Weller, M ;
Debatin, KM .
NATURE MEDICINE, 2002, 8 (08) :808-815